Blenheim Pharmacal, Inc.

FDA Regulatory Profile

Blenheim Pharmacal, Inc. appears in FDA public data with 2 recalls, 0 510(k) clearances, 7 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-1109-2015, Class II) was initiated on May 22, 2015.

Summary

Total Recalls
2
510(k) Clearances
0
Inspections
7
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-1109-2015Class IICaptopril Tablets, USP, 50 mg, 30 Tablets, Rx Only, Dist. By: Wockhardt USA LLC, Parsippany, NJ 0705May 22, 2015
D-1110-2015Class IIClarithromycin Tablets, USP, 500 mg, 20 Tablets, Rx Only, Dist. By: Wockhardt USA LLC, Parsippany, NMay 22, 2015